BDBM329729 (3R,4S)-1-(1-(2-chloro-6-cyclopropyl benzoyl)-4-fluoro-1H-indazol-3-yl)-3-hydroxy-4-methylpiperidine-4-carboxylic acid::US9663522, 9A

SMILES C[C@@]1(CCN(C[C@@H]1O)c1nn(C(=O)c2c(Cl)cccc2C2CC2)c2cccc(F)c12)C(O)=O

InChI Key InChIKey=DXBRGPBHJUIWHM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 329729   

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM329729(US9663522, 9A | (3R,4S)-1-(1-(2-chloro-6-cycloprop...)
Affinity DataIC50: 2nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent